JAN 15, 2019 04:00 PM SGT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Flexible manufacturing strategies for cell and gene therapy products

SPONSORED BY: TERUMO BCT
C.E. CREDITS: P.A.C.E. CE | Florida CE
Speakers
  • Cell Processing Specialist, APAC Region, Terumo BCT
    Biography
      Wenyan Leong is a regional expert for the Cell Therapy Technologies portfolio of Terumo BCT. Responsible for managing knowledge transfer and implementation of efficient and safe manufacturing solutions in the biotechnology and cell therapy fields, Dr. Leong works closely with various industry representatives, researchers and clinicians throughout Asia Pacific. She is very passionate about the advances in cell- and gene-based therapy and seeks active dialogue with stakeholders in the field on bringing innovation to patients in need.

      Prior to joining Terumo BCT, Leong spent four productive years conducting academic research on cell-based regenerative medicine platforms, working on a variety of cell types and biomaterials. Her contribution of 10 research articles and three patents to this specialty resulted in a PhD in Bioengineering from Nanyang Technological University, Singapore.

    Abstract:

    DATE: January 15, 2019

    TIME:  4:00pm SGT

    There is a clear call to automate manufacturing for cell and gene therapy products, but when should you automate? In this session, we will consider the shifting priorities as you move from product development towards clinical manufacturing and discuss how choosing the right type of automation can create immediate impact without compromising flexibility. Case studies in adherent and suspension cell expansion, gene modification and cell secretome production will be presented.

    Who may be interested:

    • Clinicians, researchers, lab technologists and cell therapy industry professional
    • Cell and gene therapy manufacturing professionals
    • Contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs)

     

    Key learning objectives:

    • Understand the impact of Investigational New Drug submission on the manufacturing process
    • Learn how various adopters of the Quantum® Cell Expansion System have improved their manufacturing processes

    Show Resources
    You May Also Like
    MAY 22, 2018 08:00 AM PDT
    C.E. CREDITS
    MAY 22, 2018 08:00 AM PDT
    DATE: May 22, 2018TIME: 08:00AM PDT The nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR) are closely related transcription factors that...
    MAY 03, 2018 11:00 AM PDT
    MAY 03, 2018 11:00 AM PDT
    DATE: May 3, 2018TIME: 11:00AM PDT, 2:00PM EDTWhile stress is one of the leading causes of neuropsychiatric disorders, the molecular underpinnings of how stress induces alterations in b...
    APR 26, 2018 07:30 AM PDT
    C.E. CREDITS
    APR 26, 2018 07:30 AM PDT
    DATE: April 26, 2018TIME: 07:30am PDT, 04:30pm CESTThe NGS library preparation process is labor-intensive, requiring experience and attention to detail over hours. Eppendorf consumables...
    AUG 15, 2018 08:00 AM PDT
    C.E. CREDITS
    AUG 15, 2018 08:00 AM PDT
    DATE: August 15, 2018TIME: 08:00AM PDT, 11:00AM EDTThe failure of current chemotherapeutic strategies in the fight against cancer can be largely attributed to the occurrence of drug res...
    APR 27, 2018 10:00 AM PDT
    C.E. CREDITS
    APR 27, 2018 10:00 AM PDT
    DATE: April 27, 2018TIME: 10:00am PST, 1:00pm ESTGlioblastoma (GBM) and Medulloblastoma (MB) are the most common adult and paediatric brain tumours, both of which can have devastating c...
    JUN 26, 2018 06:00 AM PDT
    C.E. CREDITS
    JUN 26, 2018 06:00 AM PDT
    Date: June 26, 2018Time: 6:00 a.m. PDT, 9:00 a.m. EDT, 1500 CEST Today’s hematology analyzers employ various methods for enumerating platelets. These methods include: e...
    Loading Comments...